Cinven is reviewing strategic options for laboratory-services company Synlab International GmbH including a potential sale, people with knowledge of the matter said.
The private equity firm has been speaking with potential advisers and could start a sale process early next year, the people said, asking not to be identified because the information is private. Cinven plans to seek a valuation of about 5.5 billion euros ($6 billion) including debt for Augsburg, Germany-based Synlab, one of the people said.
A sale of Synlab would likely attract other private equity firms, the people said. No final decision has been made, and Cinven could elect to keep the business, the people said. A spokeswoman for Cinven declined to comment, while Synlab didn’t answer phone calls seeking comment.
Cinven first invested in Synlab in June 2015, buying a majority stake from fellow private equity firm BC Partners for about 1.7 billion euros, Bloomberg News reported at the time. It combined the business with Labco SA, which it agreed to buy earlier that year for 1.2 billion euros.
Synlab, led by Chief Executive Officer Mathieu Floreani, also counts Novo A/S and Ontario Teachers’ Pension Plan as minority investors, according to its website. It operates across more than 40 countries, handling more than 500 million clinical tests annually, according to Synlab’s website.
Cinven also owns stakes in retailer Kurt Geiger and German drugmaker Stada Arzneimittel AG, according to its website.
The sale plan comes at a time when Cinven’s rival Apax Partners is also weighing a sale of diagnostic services business Unilabs. The buyout firm is working with advisers at Rothschild & Co. to look at options for the business, people familiar with the matter said last week.
Source: Bloomberg
Can’t stop reading? Read more
Update: Sycamore Partners nears finish line in $10bn Walgreens takeover
Update: Sycamore Partners nears finish line in $10bn Walgreens takeover Sycamore Partners is finalizing a deal to acquire Walgreens Boots Alliance in a transaction valued at around $10bn, according to sources familiar with the matter. The acquisition, which could be...
Warburg Pincus sells Sundyne to Honeywell in $2.2bn private equity exit
Warburg Pincus sells Sundyne to Honeywell in $2.2bn private equity exit Warburg Pincus finalised the sale of industrial pump and gas compressor manufacturer Sundyne to Honeywell International in a $2.2bn all-cash deal. The transaction values Colorado-based Sundyne at...
BGF backs OCL Vision’s growth as it expands across the UK
BGF backs OCL Vision’s growth as it expands across the UK BGF made a significant multi-million-pound investment in OCL Vision, a fast-growing ophthalmology group, to support its expansion across the UK. Founded in 2018 by leading eye surgeons Ali Mearza, Allon Barsam,...